Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: OCGN stock price vs MNST: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MNST's multiple
Needs MNST P/S.
Implied fair value · at OCGN's multiple
Needs OCGN P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OCGN FY 2025 (ended Dec 31, 2025) · MNST FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
OCUGEN, INC. · implied price per share
Bear
-$0.05
Base
-$0.06
Bull
-$0.07
Monster Beverage Corp · implied price per share
Bear
$19.73
Base
$23.21
Bull
$26.70
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-2.37x
0.05x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
-0.95x
Cash and equivalents
Liquid reserves on the balance sheet
$19.47M
$2.77B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
IOVANCE BIOTHERAPEUTICS, INC.
OCGN vs IOVA
bluebird bio, Inc.
OCGN vs BLUE
BioNTech SE
OCGN vs BNTX
Moderna, Inc.
OCGN vs MRNA
Legend Biotech Corp
OCGN vs LEGN
Arcturus Therapeutics Holdings Inc.
OCGN vs ARCT
COCA COLA CO
OCGN vs KO
PEPSICO INC
OCGN vs PEP
Keurig Dr Pepper Inc.
OCGN vs KDP
NATIONAL BEVERAGE CORP
OCGN vs FIZZ
MOLSON COORS BEVERAGE CO
OCGN vs TAP
BROWN FORMAN CORP
OCGN vs BF-A
$28.79M
$373.95M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
